Volume 44, Issue 3 pp. 454-460
ORIGINAL ARTICLE

Changes in peripheral blood cellular morphology as diagnostic markers for COVID-19 infection

Hala Gabr

Hala Gabr

Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Clinical and Chemical Pathology Department, Faculty of Medicine, Helwan University, Cairo, Egypt

Search for more papers by this author
Samah Bastawy

Samah Bastawy

Clinical and Chemical Pathology Department, Faculty of Medicine, Helwan University, Cairo, Egypt

Search for more papers by this author
Asmaa A. Abdel_Aal

Asmaa A. Abdel_Aal

Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Search for more papers by this author
Noha M. Khalil

Noha M. Khalil

Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Search for more papers by this author
Mohamed Fateen

Corresponding Author

Mohamed Fateen

Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

Correspondence

Mohamed Fateen, Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, 16 Messaha Square, Dokki, Cairo 12311, Egypt.

Email: [email protected]

Search for more papers by this author
First published: 19 January 2022
Citations: 7

Abstract

Introduction

Real-time reverse-transcriptase polymerase chain reaction (RT-PCR) assays were established to detect severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). However, due to the high rate of false negative results, additional tests as computed tomography (CT) scans of the chest and blood chemistry are required to properly diagnose COVID-19 infection. Abnormal morphological changes of peripheral blood cells as granulocytic dysmorphism and abnormal reactive lymphocytes have been described in some cases. The aim of the present study was to investigate the morphological changes affecting all peripheral blood cells of COVID-19 patients, in order to find any specific abnormalities that could help in the early diagnosis and/or prognosis.

Methods

Peripheral blood smears of 113 COVID-19 patients and 50 non-COVID-19 controls were examined for morphological changes in the period between October 2020 and January 2021 (second wave). We set a score value in which every morphological abnormality was given one point in each examined blood smear. Score, neurophil/lymphocyte (N/L) ratio, and blood chemistry were compared to the severity and outcome of the disease.

Results

Significant morphological changes were found when compared to control blood smears. Various abnormalities as pyknotic cells, broken cells, pseudo Pelger-Huët, abnormal lymphocytes, abnormal monocytes, and leukoerythroblastic reaction were found. Cases with higher scores had unfavorable outcomes (p = .005). High interleukin-6 (IL-6) levels were correlated to pyknotic cells (p = .003).

Conclusion

The blood picture of COVID-19 patients revealed various morphological changes that are not detected with the same frequency and variability in other viral infections. The prominent morphological changes can be predictive of an undesirable outcome of the disease.

CONFLICT OF INTEREST

The authors have no competing interests.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.